(2S)-N-[(3S)-7-cyano-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-2-oxo-5-(pyridine-4-carbonyl)-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide

C35H29N9O3 — CID 118077220

IUPAC(2S)-N-[(3S)-7-cyano-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-2-oxo-5-(pyridine-4-carbonyl)-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide
SMILESCN[C@@H](C)C(=O)N[C@H]1CN(C(=O)c2ccncc2)c2cc(C#N)ccc2N(Cc2nn(-c3ccccc3C#N)c3ccccc23)C1=O
InChIInChI=1S/C35H29N9O3/c1-22(38-2)33(45)40-28-21-43(34(46)24-13-15-39-16-14-24)32-17-23(18-36)11-12-31(32)42(35(28)47)20-27-26-8-4-6-10-30(26)44(41-27)29-9-5-3-7-25(29)19-37/h3-17,22,28,38H,20-21H2,1-2H3,(H,40,45)/t22-,28-/m0/s1
InChIKeyQZIVNKNQWYOBJD-DWACAAAGSA-N
MW623.68 g/mol
LogP3.45
Rot. Bonds7

About (2S)-N-[(3S)-7-cyano-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-2-oxo-5-(pyridine-4-carbonyl)-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide

(2S)-N-[(3S)-7-cyano-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-2-oxo-5-(pyridine-4-carbonyl)-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide (PubChem CID 118077220) has the molecular formula C35H29N9O3 and a molecular weight of 623.68 g/mol. Its IUPAC name is (2S)-N-[(3S)-7-cyano-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-2-oxo-5-(pyridine-4-carbonyl)-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide.

Molecular Properties

Compound Name(2S)-N-[(3S)-7-cyano-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-2-oxo-5-(pyridine-4-carbonyl)-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide
PubChem CID118077220
Molecular FormulaC35H29N9O3
Molecular Weight623.68 g/mol
Exact Mass623.24
IUPAC Name(2S)-N-[(3S)-7-cyano-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-2-oxo-5-(pyridine-4-carbonyl)-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide
SMILESCN[C@@H](C)C(=O)N[C@H]1CN(C(=O)c2ccncc2)c2cc(C#N)ccc2N(Cc2nn(-c3ccccc3C#N)c3ccccc23)C1=O
InChIInChI=1S/C35H29N9O3/c1-22(38-2)33(45)40-28-21-43(34(46)24-13-15-39-16-14-24)32-17-23(18-36)11-12-31(32)42(35(28)47)20-27-26-8-4-6-10-30(26)44(41-27)29-9-5-3-7-25(29)19-37/h3-17,22,28,38H,20-21H2,1-2H3,(H,40,45)/t22-,28-/m0/s1
InChIKeyQZIVNKNQWYOBJD-DWACAAAGSA-N
XLogP3.45
TPSA160.04 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms47
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500623.68
LogP ≤ 53.45
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Analyze (2S)-N-[(3S)-7-cyano-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-2-oxo-5-(pyridine-4-carbonyl)-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[(3S)-7-cyano-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-2-oxo-5-(pyridine-4-carbonyl)-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide?
The IUPAC name of (2S)-N-[(3S)-7-cyano-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-2-oxo-5-(pyridine-4-carbonyl)-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide (CID 118077220) is (2S)-N-[(3S)-7-cyano-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-2-oxo-5-(pyridine-4-carbonyl)-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide.
What is the SMILES notation for (2S)-N-[(3S)-7-cyano-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-2-oxo-5-(pyridine-4-carbonyl)-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide?
The canonical SMILES for (2S)-N-[(3S)-7-cyano-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-2-oxo-5-(pyridine-4-carbonyl)-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide is CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)c2ccncc2)c2cc(C#N)ccc2N(Cc2nn(-c3ccccc3C#N)c3ccccc23)C1=O.
What is the InChIKey of (2S)-N-[(3S)-7-cyano-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-2-oxo-5-(pyridine-4-carbonyl)-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide?
The InChIKey is QZIVNKNQWYOBJD-DWACAAAGSA-N. The full InChI is InChI=1S/C35H29N9O3/c1-22(38-2)33(45)40-28-21-43(34(46)24-13-15-39-16-14-24)32-17-23(18-36)11-12-31(32)42(35(28)47)20-27-26-8-4-6-10-30(26)44(41-27)29-9-5-3-7-25(29)19-37/h3-17,22,28,38H,20-21H2,1-2H3,(H,40,45)/t22-,28-/m0/s1.
What are the key properties of (2S)-N-[(3S)-7-cyano-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-2-oxo-5-(pyridine-4-carbonyl)-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide?
(2S)-N-[(3S)-7-cyano-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-2-oxo-5-(pyridine-4-carbonyl)-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide has a molecular weight of 623.68 g/mol, XLogP of 3.45, 7 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[(3S)-7-cyano-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-2-oxo-5-(pyridine-4-carbonyl)-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide is sourced from PubChem (CID 118077220), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).